Tag: NYR

Nyrada podcast ASX NYR James Bonnar biotechvideo

Nyrada CEO James Bonnar discusses the company’s commercialisation plans – Podcast

Junior biotech company Nyrada (ASX: NYR) was the first IPO off the mark for 2020, with the company’s stock floating on the ASX in...
Nyrada blood cholesterol lowering drug studies ASX NYR protein PCSK9

Nyrada cholesterol-lowering drug studies validated in peer reviewed medical journal

Drug discoverer and early stage developer Nyrada (ASX: NYR) has had a significant advance made in the pre-clinical studies of its cholesterol-lowering drug program...
Nyrada ASX IPO

Noxopharm’s US biotech subsidiary Nyrada IPO successfully raises $8.5m

Australian biotech Noxopharm’s (ASX: NOX) US spin-off Nyrada Inc (ASX: NYR) experienced strong demand in its initial public offering and will now make its ASX...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS